🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Connect is focused on innovating best-in-class therapies to address patient needs globally. Visit here to learn more about Connect Biopharma's mission to improve lives worldwide: connectbiopharm.com

Read more about us and our latest round of financing in FierceBiotech: fiercebiotech.com/biotech/connec…

We are pleased to announce we have completed our $115 million Series C Financing to advance ongoing clinical trials and best-in-class therapies for inflammatory/autoimmune diseases: connectbiopharm.com/article272/det…

Connect Biopharma is pleased to announce that the first patient has been dosed in a Phase 2 trial evaluating CBP-201 in adult patients with moderate-to-severe persistent asthma. bit.ly/3ocRIFW #ConnectWithInnovation

$CNTB announces that the first subject has been dosed in a Phase 1 trial evaluating CBP-174 in healthy adults. CBP-174 is being developed as a potential treatment for the chronic pruritus (itch) associated with skin inflammation. bit.ly/34fW0TD #ConnectWithInnovation

Connect Biopharma is pleased to announce that Dr. Zheng Wei, Co-Founder & CEO, will participate in a fireside chat at the SVB Leerink 11th Annual Global Healthcare Conference on 2/16. #PharmaNews To learn more, visit: bit.ly/3JaiI1Q

We are proud to announce the appointment of our new Chief Medical Officer, Chin Lee, MD, MPH, who brings more than 15 years of clinical research and development experience in the biopharmaceutical industry to Connect #Biopharma. To learn more, visit: bit.ly/3C1HgYs